Abstract
Positron emission tomography/computed tomography (PET/CT) using [18F]-fluoro-2-deoxy-D-glucose (FDG) has become the mainstay imaging modality for evaluating oncology patients with certain cancers. The most common FDG PET/CT applications include staging/restaging, assessing response to therapy and detecting tumor recurrence. It is important to be aware of potential pitfalls and technical artifacts on PET/CT in the chest and abdomen to ensure accurate interpretation, avoid unnecessary intervention and optimize patient care.
Original language | English (US) |
---|---|
Pages (from-to) | 488-495 |
Number of pages | 8 |
Journal | Seminars in Ultrasound, CT and MRI |
Volume | 45 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2024 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging